Full Text
New Approach to Budget Impact Analysis - Ibrutinib In Treatment of Relapsed/Refractory Cll Patients in The Czech Republic

Abstract

Authors

L Pribylova B Pasztor S Vesela M Vyhnankova J Doleckova J Duba M Kolek

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×